COMPASS Pathways plc (CMPS) stock
CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.12+0.14 (+1.75%)
Close on Nov 18, 2026Market cap $1.12BP/E –Yield –
COMPASS Pathways free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
COMPASS Pathways's free cash flow for the twelve months ending Dec 31, 2024 was -$119.19M. For fiscal 2024 it was -$119.19M. The highest annual figure on record is -$17.98M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$119.19M | – |
| FY2023 | Dec 31, 2023 | -$97.44M | – |
| FY2022 | Dec 31, 2022 | -$106.05M | – |
| FY2021 | Dec 31, 2021 | -$68.08M | – |
| FY2020 | Dec 31, 2020 | -$41.51M | – |
| FY2019 | Dec 31, 2019 | -$17.98M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$41.76M | – |
| Q3 FY2024 | Sep 30, 2024 | -$22.19M | – |
| Q2 FY2024 | Jun 30, 2024 | -$34.42M | – |
| Q1 FY2024 | Mar 31, 2024 | -$20.83M | – |
| Q4 FY2023 | Dec 31, 2023 | -$27.78M | – |
| Q3 FY2023 | Sep 30, 2023 | -$17.08M | – |
| Q2 FY2023 | Jun 30, 2023 | -$24.83M | – |
| Q1 FY2023 | Mar 31, 2023 | -$27.75M | – |
| Q4 FY2022 | Dec 31, 2022 | -$45.41M | – |
| Q3 FY2022 | Sep 30, 2022 | -$19.02M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.42M | – |
| Q1 FY2022 | Mar 31, 2022 | -$23.21M | – |
| Q4 FY2021 | Dec 31, 2021 | -$22.46M | – |
| Q3 FY2021 | Sep 30, 2021 | -$13.98M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.79M | – |
| Q1 FY2021 | Mar 31, 2021 | -$13.85M | – |
| Q4 FY2020 | Dec 31, 2020 | -$16.78M | – |
| Q3 FY2020 | Sep 30, 2020 | -$13.92M | – |
See a number that looks wrong?